A Practical and Time-Efficient High-Intensity Interval Training Program Modifies Cardio-Metabolic Risk Factors in Adults with Risk Factors for Type II Diabetes

The researchers tested a practical, time-efficient high-intensity interval training (HIT) protocol called "5-by-1 HIT" against a comparison group that did not exercise. The intervention consisted of:

**5-by-1 HIT protocol:** Three supervised cycling sessions per week for 6 weeks. Each session included a 2-minute warm-up at 50 watts, followed by five 1-minute intervals of cycling at ~125% of the participant's maximum aerobic capacity (VO₂max), with 1 minute of recovery between each interval. Total session time: approximately 15 minutes.

**Initial 7-by-1 HIT protocol (discontinued):** A higher-volume version with seven 1-minute intervals at ~100% VO₂max, also three times per week for 6 weeks. This was discontinued after 40 participants because it produced smaller improvements in aerobic capacity.

**Comparison group:** 13 participants who did not undergo any structured exercise training but completed the same pre- and post-testing measurements.

The primary outcome was change in aerobic capacity (VO₂max). Secondary outcomes included:

Mean arterial blood pressure (MAP)

Insulin resistance measured by homeostatic model assessment (HOMA-IR)

Fasting glucose and insulin levels

Body composition (BMI, waist circumference)

Physical activity levels measured by Actiheart™ monitors

The researchers also conducted a meta-analysis comparing the 5-by-1 HIT results to a traditional 30-week, 150-minute-per-week aerobic exercise program from published literature.

**Sample size:** 189 participants total (101 women, 88 men), though the primary analysis focused on 136 who completed the 5-by-1 HIT protocol, 40 who completed the 7-by-1 protocol, and 13 in the comparison group.

**Population:** Sedentary adults with risk factors for type 2 diabetes, recruited across five European sites:

Nottingham, UK (n=37)

Loughborough, UK (n=18)

Stockholm, Sweden (n=36)

Copenhagen, Denmark (n=48)

Las Palmas de Gran Canaria, Spain (n=50)

**Characteristics:**

Age: mean 36 years (range 18–53)

BMI: mean 32.0 kg/m² (range 26.6–48.0)—all participants had BMI >27 kg/m² or impaired fasting glucose (>5.5 mmol/L)

All classified as sedentary (<600 MET-minutes per week on the International Physical Activity Questionnaire)

Excluded if they had active cardiovascular, cerebrovascular, respiratory, gastrointestinal, or renal disease; history of malignancy; coagulation dysfunction; musculoskeletal or neurological disorders; recent steroid or hormone replacement therapy; or any condition requiring long-term medication

**Setting:** University exercise physiology laboratories across five European centers, with all training sessions fully supervised.

**Aerobic capacity (VO₂max):** Measured using a graded exercise test on a cycle ergometer with breath-by-breath gas analysis. Participants cycled at increasing workloads until volitional exhaustion. VO₂max was defined as the highest 30-second average oxygen uptake during the test. This was measured before training, after the 6-week program, and again after a 3-week detraining period.

**Mean arterial blood pressure (MAP):** Calculated from systolic and diastolic blood pressure measurements taken under standardized conditions (resting, seated position). MAP = diastolic pressure + 1/3(systolic – diastolic).

**Insulin resistance (HOMA-IR):** Calculated from fasting blood samples using the formula: HOMA-IR = (fasting insulin in mU/L × fasting glucose in mmol/L) / 22.5. Higher values indicate greater insulin resistance.

**Physical activity monitoring:** Participants wore Actiheart™ monitors (combined accelerometer and heart rate monitor) for four weeklong periods: before training, during weeks 1–2, during weeks 5–6, and during the 3-week detraining period. This allowed researchers to quantify total physical activity and determine whether the HIT sessions added to or replaced participants' usual activity.

**Body composition:** Height, weight, BMI, and waist circumference measured using standardized protocols.

**Fasting blood markers:** Glucose, insulin, and lipid profiles measured from venous blood samples taken after an overnight fast.

**Study design:** This was a multi-center, non-randomized intervention study with a rolling, adaptive design. The researchers used a "multi-arm multi-stage" philosophy—they monitored the HIT protocol's efficacy on a rolling basis by aggregating VO₂max training responses as they went along. When the initial 7-by-1 protocol showed smaller-than-desired effects, they discontinued it and switched to the higher-intensity 5-by-1 protocol.

**Comparison group:** 13 participants served as a non-exercising comparison group. These were not randomly assigned—they were individuals who completed pre- and post-testing but did not undergo training. This is a major methodological limitation.

**Supervision and compliance:** All training sessions were fully supervised by research staff. Participants were required to attend all sessions; they were discontinued if they missed more than two consecutive sessions, missed more than three total sessions (~15%), or failed to complete their prescribed exercise regime on two or more occasions. No participants were discontinued for these reasons.

**Duration:** 6 weeks of training (18 sessions total), plus a 3-week detraining period where participants stopped exercising but continued wearing Actiheart monitors.

**Statistical approach:**

Primary analysis used paired t-tests or Wilcoxon signed-rank tests for within-group changes

Between-group comparisons used ANOVA or Kruskal-Wallis tests

Effect sizes reported as Cohen's d (large effect = d > 0.8)

Meta-analysis compared the 5-by-1 HIT results to a traditional 30-week aerobic training program using standardized mean differences

Inter-individual variability was assessed by calculating the standard deviation of individual responses

**What this design can and cannot prove:**

**Can prove:** That the 5-by-1 HIT protocol produces statistically significant changes in VO₂max, blood pressure, and insulin resistance in this specific population over 6 weeks. The supervised, standardized protocol ensures high internal validity for the training stimulus.

**Cannot prove:**

**Causality:** Without random assignment to HIT versus a true control group, we cannot definitively attribute changes to the exercise intervention. The comparison group was small (n=13) and not randomized.

**Generalizability:** Participants were relatively young (mean 36 years), sedentary but otherwise healthy (no chronic diseases, no medications), and highly motivated (no dropouts for non-compliance). Results may not apply to older adults, those with established diabetes, or less motivated individuals.

**Long-term effects:** 6 weeks is short. The 3-week detraining follow-up is helpful but doesn't tell us about 6-month or 1-year outcomes.

**Diabetes prevention:** The study measured risk factors (VO₂max, blood pressure, insulin resistance), not actual diabetes incidence. The authors explicitly state that long-term randomized controlled trials are needed to determine whether this protocol reduces diabetes incidence.

**Comparison to other exercise protocols:** The meta-analysis comparing to a 30-week program is informative but limited by differences in study populations, measurement methods, and the fact that the comparison data came from published literature rather than a head-to-head trial.

**Major methodological weaknesses:**

1. **No randomization**—this is the most significant limitation

2. **Small comparison group** (n=13) with different characteristics (more women, lower BMI on average)

3. **No blinding**—participants and researchers knew who was exercising

4. **Adaptive design**—changing protocols mid-study based on interim results reduces statistical validity

5. **No intention-to-treat analysis**—only completers were analyzed

6. **Potential for regression to the mean**—participants were selected for having risk factors, so some improvement might occur naturally

**Primary outcome—VO₂max:**

5-by-1 HIT: Increased by 10.0% (p < 0.001, large effect size, Cohen's d > 0.8)

7-by-1 HIT: Increased by 5.6% (p < 0.05)

Comparison group: No significant change

After 3 weeks of detraining: ~50% of the VO₂max improvement was retained (exact percentage not reported, but described as "sizeable proportion")

**Secondary outcomes—5-by-1 HIT group:**

**Mean arterial blood pressure (MAP):**

Reduced by ~3% (p < 0.001)

This corresponds to approximately 3-4 mmHg reduction in MAP

Effect was partially retained after 3 weeks of detraining

**Insulin resistance (HOMA-IR):**

Reduced by ~16% (p < 0.01)

This is a substantial improvement in a key diabetes risk marker

Effect was partially retained after 3 weeks of detraining

**Fasting glucose and insulin:**

Fasting glucose: No significant change reported

Fasting insulin: Reduced, consistent with the HOMA-IR improvement

**Body composition:**

BMI: No significant change

Waist circumference: No significant change reported

**Physical activity monitoring:**

The supervised HIT sessions accounted for the entire quantifiable increase in physical activity

This equated to approximately 400 MET-minutes per week from the HIT sessions alone

Participants did not compensate by reducing their non-exercise physical activity (nor did they increase it)

**Gender differences:**

Physiological responses were similar in men and women

No significant gender-by-training interactions

**Meta-analysis results:**

5-by-1 HIT matched the efficacy of a traditional 30-week, 150-minute-per-week aerobic exercise program for improving VO₂max, MAP, and HOMA-IR

The variability in individual responses was similar between the 6-week HIT program and the 30-week traditional program

**Inter-individual variability:**

While average improvements were significant, individual responses varied widely

Some participants showed large improvements, while others showed minimal or even negative responses

This variability was not explained by age, sex, baseline fitness, or baseline BMI

**Aerobic capacity:** A 10% increase in VO₂max is substantial. For context, a typical 6-week moderate-intensity exercise program (150 minutes/week) might produce a 5-8% improvement. This means the 5-by-1 HIT protocol, with only ~45 minutes of total exercise per week, produced improvements comparable to or better than programs requiring 3-4 times more time commitment.

**Blood pressure:** A ~3% reduction in MAP (approximately 3-4 mmHg) is clinically meaningful. Population-level studies suggest that a 2 mmHg reduction in systolic blood pressure reduces stroke mortality by ~10% and coronary heart disease mortality by ~7%. The effect is roughly equivalent to what you might expect from a low-dose blood pressure medication or a DASH diet intervention.

**Insulin resistance:** A 16% reduction in HOMA-IR is substantial. For comparison, metformin (the most common diabetes medication) typically reduces HOMA-IR by 20-30% over several months. A 16% reduction from just 6 weeks of exercise is impressive and suggests meaningful improvement in metabolic health.

**Time efficiency:** The total weekly exercise time was approximately 15 minutes per session × 3 sessions = 45 minutes of actual exercise, plus warm-up and cool-down bringing total commitment to about 15 minutes per session. This is roughly 70% less time than the standard 150-minute-per-week recommendation.

**Detraining:** The fact that ~50% of benefits were retained after 3 weeks of no exercise suggests that even intermittent training (e.g., 6 weeks on, 3 weeks off) might provide cumulative benefits, though this was not directly tested.

**Author-acknowledged limitations:**

1. Long-term randomized controlled trials are needed to determine whether this protocol reduces actual diabetes incidence

2. Strategies are needed to harmonize adaptations across individuals (i.e., reduce the high inter-individual variability)

3. The study was not a randomized clinical trial

4. The adaptive design (switching from 7-by-1 to 5-by-1 mid-study) limits statistical interpretation

**Critical reader observations:**

**Design limitations:**

**No randomization:** This is the most critical flaw. Without random assignment, we cannot rule out that participants who chose to exercise were more motivated or health-conscious, and that some improvements might have occurred without exercise.

**Small comparison group:** Only 13 participants served as controls, and they differed from the intervention groups (more women, lower BMI). This makes the comparison unreliable.

**No blinding:** Participants knew they were exercising, which could influence outcomes through expectation effects (especially for subjective measures, though VO₂max is objective).

**No placebo control:** There was no sham exercise or attention-control group to account for the effects of regular contact with research staff.

**Population limitations:**

**Young and healthy:** Mean age 36, all free of chronic disease and medications. Results may not generalize to older adults or those with established diabetes.

**Highly selected:** Participants had to be sedentary but willing to commit to supervised training 3x/week for 6 weeks. This selects for motivated individuals.

**No dropouts for non-compliance:** This is unusual and suggests the sample was highly motivated, which may not reflect real-world adherence.

**Measurement limitations:**

**HOMA-IR is a surrogate:** It estimates insulin resistance from fasting glucose and insulin but doesn't directly measure insulin sensitivity (which requires a clamp procedure).

**Short duration:** 6 weeks is too short to assess long-term adherence or sustained health benefits.

**No dietary control:** Participants were not instructed to change their diet, but dietary changes were not monitored. Some improvements could be due to unmeasured dietary changes.

**Analysis limitations:**

**Completer analysis only:** Only participants who finished the program were included. If dropouts had worse outcomes, results would be inflated.

**Multiple comparisons:** Many outcomes were tested without correction for multiple comparisons, increasing the risk of false positives.

**Meta-analysis limitations:** Comparing to published literature rather than a head-to-head trial introduces many confounders (different populations, measurement methods, time periods).

**Generalizability concerns:**

**Equipment required:** The protocol used specialized cycle ergometers (Corival or Excalibur Sport, Lode). Whether results generalize to cheaper stationary bikes or outdoor cycling is unknown.

**Supervision required:** All sessions were fully supervised. Whether unsupervised HIT produces similar results is unknown (and likely not, given safety and motivation concerns).

**Intensity precision:** The protocol required cycling at exactly 125% of VO₂max, which requires prior testing and calibrated equipment. Real-world application would need to use perceived exertion or heart rate zones.

For someone running their own n=1 experiment:

### What to test (specific intervention and dose)

**The 5-by-1 HIT protocol:**

Frequency: 3 times per week (non-consecutive days)

Duration: 6 weeks minimum (18 sessions total)

Each session:

- 2-minute warm-up at very easy effort (e.g., 50 watts on a bike, or very light resistance)

- 5 rounds of: 1 minute at maximum sustainable effort (should feel "all-out" or close to it), followed by 1 minute of easy recovery (slow pedaling or rest)

- Total session time: approximately 12-15 minutes

Intensity target: You should be unable to speak more than a few words during the 1-minute work intervals. On a 1-10 scale of perceived exertion, aim for 9-10.

**Equipment needed:**

Stationary bike (any type—spin bike, upright, recumbent)

Heart rate monitor (optional but helpful for tracking)

-